AvoMD partners with Mass General Brigham to develop inpatient emergency clinical care algorithms

FHS
March 6, 2024
5:25 pm

Mass General Brigham, a leading integrated academic health care system, and the Healthcare Transformation Lab at Massachusetts General Hospital are proud to announce their collaboration with AvoMD, a digital clinical decision support platform that brings current medical evidence into the clinical workflow, to develop a series of inpatient emergency clinical care algorithms.

Extracellular vesicle miRNAs as potential early biomarkers for acute myocardial infarction

Announcing a new article publication for Cardiovascular Innovations and Applications journal. This study sought to determine the potential of extracellular vesicle (EV) microRNAs (miRNAs) to

January 17, 2025

Cancer cells hijack enhancer DNA to grow faster, study finds

University of Toronto researchers have found that cancer cells can enhance tumor growth by hijacking enhancer DNA normally used when tissues and organs are formed.

September 30, 2023

ChromaDex wins orphan designation for rare ataxia drug – Pharmaceutical Technology

Ataxia telangiectasia is a rare, inherited, progressive childhood disorder for which symptoms manifest neurologically and immunologically. Chromadex is developing a candidate to treat ataxia telangiectasia.

June 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.